SFM
GCVRZ

Sphera Funds Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Sphera Funds Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-67,960
Closed -$6.22M – 191
2014
Q4 		$6.22M Hold
67,960
– – 1.06% 22
2014
Q3 		$7.69M Buy
+67,960
New +$33K 0.95% 27

Other funds holding GCVRZ

WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Sphera Funds Management's GCVRZ Position: Q1 2015 in Review

Sphera Funds Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2015, closing a stake of 67,960 shares — an estimated $6.22M sold.

Sphera Funds Management first reported a position in GCVRZ in Q3 2014 and held it in 2 quarters. The position peaked at $7.69M in Q3 2014. 115 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2015.

  • Sphera Funds Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2015 after selling out during the quarter.
  • Sphera Funds Management sold 67,960 Sanofi Contingent Value Rights shares in Q1 2015, an estimated $6.22M.
  • Sphera Funds Management first reported a position in Sanofi Contingent Value Rights in Q3 2014 and held it in 2 quarters.
  • Sphera Funds Management's Sanofi Contingent Value Rights position peaked at $7.69M in Q3 2014.
  • 115 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2015.

Based on Sphera Funds Management's 13F filing for Q1 2015, filed 11 May 2015.